Is Immage Biotherapeutics Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Immage Biotherapeutics Corp (IMMG) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Immage Biotherapeutics Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Immage Biotherapeutics Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Immage Biotherapeutics Corp?

Muslim investors may consider investing in Immage Biotherapeutics Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Immage Biotherapeutics Corp classified as NOT COVERED?

Musaffa determines the Shariah status of Immage Biotherapeutics Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Immage Biotherapeutics Corp updated?

The Shariah compliance status of Immage Biotherapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Immage Biotherapeutics Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Immage Biotherapeutics Corp?

You can check the latest Shariah compliance status of Immage Biotherapeutics Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Immage Biotherapeutics Corp. Stock Analysis IMMG

United States N/A Nano Cap

Immage Biotherapeutics Corp. is a biotechnology company, which develops novel immunotherapy biologics to treat various cancers. The firm is engaged in developing cancer immunotherapy through development of cutting-edge immunotherapy candidates using bioinformatics and outsourced laboratory resources. The company is focused on developing immunotherapy biologics to treat various cancers. The firm develops, markets and licenses its immunotherapy candidate for melanoma-associated antigen-A (MAGE A). The firm plans to focus on the development of immunotherapy for breast and prostate cancer. The firm focuses on developing a fusion/hybrid antigen cancer vaccine that would not only be human leukocyte antigen (HLA) free, but also be effective to all the isomers associated with MAGE A, from 1 to 11, and the identification and development of immunotherapy candidates from its intellectual property library for the preparation for human clinical trials using a viral vector construct.

Financial Metrics & Statements of Immage Biotherapeutics Corp (IMMG)

FAQ's for Immage Biotherapeutics Corp (IMMG)

According to Musaffa’s Shariah screening methodology, Immage Biotherapeutics Corp (IMMG) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.